Acute Retinal Necrosis Associated with Epstein-Barr Virus Successfully Treated with Antiviral Treatment: A Case Report. [PDF]
You H, Kim J.
europepmc +1 more source
Diagnostic and therapeutic challenges in acute retinal necrosis; an update. [PDF]
Kalogeropoulos D +4 more
europepmc +1 more source
THREE CASES OF ACUTE RETINAL NECROSIS WITH ATYPICAL FUNDUS FINDINGS. [PDF]
Chujo S +5 more
europepmc +1 more source
Optic neuropathy as an initial manifestation of acute retinal necrosis caused by varicella zoster virus: a case report. [PDF]
Li L, Wu Q, Tian Q, Han G, Xie X.
europepmc +1 more source
Varicella Zoster Virus-induced Acute Retinal Necrosis Following Acute Meningoencephalitis in a Patient with Presumed COVID-19. [PDF]
Hassanpour K +4 more
europepmc +1 more source
Long-Term Functional Outcomes of Retinal Detachment Due to Acute Retinal Necrosis: A Case Series. [PDF]
Iannetti L +7 more
europepmc +1 more source
Atypical presentation of acute retinal necrosis mimicking Vogt-Koyanagi-Harada disease leading to misdiagnosis: a case report. [PDF]
Zhu W, Yu C, Guo Q, Kang Q, Cao X.
europepmc +1 more source
Related searches:
Acute retinal necrosis represents a distinct, recently recognized clinical syndrome. Four patients who presented with rapid visual loss associated with uveitis and coalescent areas of retinal necrosis, followed by development of retinal detachments were examined.
B D, Gorman, A J, Nadel, R S, Coles
exaly +4 more sources
Acute retinal necrosis (ARN) is an uncommon intraocular inflammatory syndrome characterized by severe and diffuse uveitis, retinal vasculitis, and retinal necrosis. It is typically described to occur in immunocompetent patients, but can also be found in immunocompromised subjects.
Andrew Eller
exaly +3 more sources
Therapy for Acute Retinal Necrosis
Seminars in Ophthalmology, 2008Acute retinal necrosis is a progressive necrotizing retinopathy caused by herpes simplex virus (HSV) or varicella zoster virus (VZV). The mainstay of its treatment is antiviral therapy against these pathogenic organisms, such as intravenous acyclovir or oral valacyclovir.
Tatsushi Kawaguchi, Manabu Mochizuki
exaly +3 more sources

